PL-5028

N/A

Report date: 2023/02/26 21:49:59
NME

Base Information

Drug NamePL-5028
Drug Alias NamePL-5028
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionAtrial natriuretic peptide receptor agonists
TargetsAtrial natriuretic peptide receptor
Therapy Area/IndicationsFibrosisCardiomyopathy, Hypertrophic, Familial
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPalatin Technologies Inc
China Registration ClassN/A

Develop Information

Active CompaniesPalatin Technologies Inc
Inactive CompaniesN/A
Active IndicationsFibrosisCardiomyopathy, Hypertrophic, Familial
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A